Category: For patients

  • UGNJ to Host Prostate Cancer Awareness Event

    June-12-2013 Prostate-Cancer-Awareness-and-Survivorship I will be one of the speakers at our prostate cancer survivorship even on June 12th. This will be held at our cancer center on June 12th. This event will be open to the public and will feature physicians discussing many aspects of prostate cancer treatment and care.

  • Intuitive Robot Probe Threatens Trend-Setting Surgeries – Bloomberg

    The safety of robots made by Intuitive Surgical Inc. (ISRG) is being probed by U.S. regulators, raising questions about the prospects of one of the hottest technologies in health care. The Food and Drug Administration asked surgeons at key hospitals to list the complications they may have seen with the machines, which cost about $1.5…

  • Green Tea May Inhibit Prostate Cancer Tumor Growth – Renal and Urology News

    Drinking green tea may play a role in the inhibition of prostate cancer tumor growth, according to a study presented at the American Association for Cancer Research’s International Conference on Frontiers in Cancer Prevention Research in Anaheim, Calif. via Green Tea May Inhibit Prostate Cancer Tumor Growth – Renal and Urology News. Green tea is…

  • Domenico Savatta, MD FACS selected as “Top Cancer Doctor”

    Domenico Savatta, M.D., graduated Tau Beta Pi, and summa cum Laude from The Cooper Union with a B.S. in engineering. He then attended SUNY Stony Brook School of Medicine and was an AOA graduate. Thereafter, he completed a residency in urology at the prestigious Indiana University Medical Center, world renowned for the treatment of testicular…

  • They got it wrong again – www.phillyburbs.com: Reader Voices

    While prostate cancer is still the second leading cause of death for American men, early detection and advanced treatments have combined to reduce the mortality rate from prostate cancer by nearly 40 percent in the last two decades. During that same time period, we have seen dramatically less metastatic disease than in my earliest days…

  • Urologists Condemn Task Forces Anti-PSA Testing Stance

    The U.S. Preventive Services Task Force (USPSTF) on May 21 released its final recommendations on PSA-based screening forprostate cancer (PCa), which advises against the practice and gives it a grade D rating, meaning the task force believes there is “moderate or high certainty that the service has no net benefit or that the harms outweigh…

  • Prostate-Cancer Mortality at 11 Years of Follow-up — NEJM

    After a median follow-up of 11 years in the core age group, the relative reduction in the risk of death from prostate cancer in the screening group was 21% rate ratio, 0.79; 95% confidence interval [CI], 0.68 to 0.91; P=0.001, and 29% after adjustment for noncompliance. The absolute reduction in mortality in the screening group…

  • Statins make radiation more effective at curing prostate cancer, study suggests

    Statins Make Radiation More Effective at Curing Prostate Cancer, Study Suggests ScienceDaily (Mar. 25, 2011) — Men with high-risk prostate cancer who take statin drugs commonly used to lower cholesterol while receiving radiation therapy are less likely to have their cancer return than patients who do not take these medications, according to a study published…

  • FDA committee votes down 5-ARIs for prostate cancer risk reduction – – UrologyTimes

    “Although the REDUCE trial demonstrated a risk reduction in a large number of men, the committee chose to focus on a small number of high-grade cancers and determined that this class of drugs is inappropriate for prostate cancer risk reduction, even in the population of men with elevated PSA and previous negative biopsy,” added Dr.…